Literature DB >> 22025171

Prostate cancer: The optimal number and location of cores for repeat biopsy.

J Stephen Jones.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22025171     DOI: 10.1038/nrurol.2011.162

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  6 in total

Review 1.  Saturation biopsy for detecting and characterizing prostate cancer.

Authors:  J Stephen Jones
Journal:  BJU Int       Date:  2007-04-08       Impact factor: 5.588

2.  The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic scheme.

Authors:  Vincenzo Scattoni; Marco Raber; Umberto Capitanio; Firas Abdollah; Marco Roscigno; Diego Angiolilli; Carmen Maccagnano; Andrea Gallina; Antonio Saccà; Massimo Freschi; Claudio Doglioni; Patrizio Rigatti; Francesco Montorsi
Journal:  Eur Urol       Date:  2011-07-30       Impact factor: 20.096

3.  Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated.

Authors:  M K Terris; T Q Pham; M M Issa; J N Kabalin
Journal:  J Urol       Date:  1997-01       Impact factor: 7.450

4.  Does transrectal ultrasound probe configuration really matter? End fire versus side fire probe prostate cancer detection rates.

Authors:  Christina B Ching; Ayman S Moussa; Jianbo Li; Brian R Lane; Craig Zippe; J Stephen Jones
Journal:  J Urol       Date:  2009-03-14       Impact factor: 7.450

5.  Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies.

Authors:  Robert Abouassaly; Nelly Tan; Ayman Moussa; J Stephen Jones
Journal:  J Urol       Date:  2008-07-17       Impact factor: 7.450

6.  Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.

Authors:  W J Catalona; D S Smith; R L Wolfert; T J Wang; H G Rittenhouse; T L Ratliff; R B Nadler
Journal:  JAMA       Date:  1995-10-18       Impact factor: 56.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.